Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis

Abstract Introduction This article aims to describe malignancies in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), or non-radiographic axial spondyloarthritis (nr-axSpA) treated with upadacitinib (UPA) or active comparators. Methods This integrated s...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Andrea Rubbert-Roth, Adriana M. Kakehasi, Tsutomu Takeuchi, Marc Schmalzing, Hannah Palac, Derek Coombs, Jianzhong Liu, Samuel I. Anyanwu, Ralph Lippe, Jeffrey R. Curtis
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Adis, Springer Healthcare 2023-11-01
Σειρά:	Rheumatology and Therapy
Θέματα:	Ankylosing spondylitis (AS) Janus kinase (JAK) inhibitor Malignancy Nonmelanoma skin cancer (NMSC) Non-radiographic axial spondyloarthritis (nr-axSpA) Psoriatic arthritis (PsA)
Διαθέσιμο Online:	https://doi.org/10.1007/s40744-023-00621-6

Παρόμοια τεκμήρια

Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis
ανά: Natalie Frede, κ.ά.
Έκδοση: (2022-10-01)

Treat to Target in Spondyloarthritis: Myth or Reality?
ανά: Nelly Ziade, κ.ά.
Έκδοση: (2021-07-01)

Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis
ανά: Juergen Braun, κ.ά.
Έκδοση: (2023-05-01)

Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis
ανά: Jonas Sagard, κ.ά.
Έκδοση: (2022-02-01)

Antibodies of the immunoglobulin a isotype to novel antigens in early axial spondyloarthritis
ανά: Pieter Ruytinx, κ.ά.
Έκδοση: (2023-02-01)

Biomarkers, imaging and disease activity indices in patients with early axial spondyloarthritis: the Italian arm of the SpondyloArthritis-Caught-Early (SPACE) Study
ανά: M. Lorenzin, κ.ά.
Έκδοση: (2017-08-01)

Axial Spondyloarthritis: An Evolving Concept
ανά: Nelly Ziadé
Έκδοση: (2015-07-01)

Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials
ανά: Gerd R. Burmester, κ.ά.
Έκδοση: (2024-04-01)

Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis
ανά: Roberta Ramonda, κ.ά.
Έκδοση: (2024-07-01)

Cinematic rendering in rheumatic diseases—Photorealistic depiction of pathologies improves disease understanding for patients
ανά: Milena L. Pachowsky, κ.ά.
Έκδοση: (2022-08-01)

Comparison of Clinical Features in HLA-B27 Positive and Negative Patients With Axial Spondyloarthritis: Results From a Cohort of 4,131 Patients
ανά: Shangzhu Zhang, κ.ά.
Έκδοση: (2020-12-01)

Dual-Energy-CT for Osteitis and Fat Lesions in Axial Spondyloarthritis: How Feasible Is Low-Dose Scanning?
ανά: Dominik Deppe, κ.ά.
Έκδοση: (2023-02-01)

Axial spondyloarthritis patients have altered mucosal IgA response to oral and fecal microbiota
ανά: Tejpal Gill, κ.ά.
Έκδοση: (2022-09-01)

Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS® Short Forms: a study in patients with axial spondyloarthritis
ανά: Amy Findley, κ.ά.
Έκδοση: (2023-04-01)

Axial Spondyloarthritis in the Era of Precision Medicine: Biomarkers, Microbiota, and Multimodal Therapy
ανά: Karolina Kopeć, κ.ά.
Έκδοση: (2025-03-01)

A UK Best Practice Model for Diagnosis and Treatment of Axial Spondyloarthritis
ανά: Rebecca Adshead, κ.ά.
Έκδοση: (2015-07-01)

Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain
ανά: Cristina Valero-Martínez, κ.ά.
Έκδοση: (2023-10-01)

Coping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation
ανά: Diego Benavent, κ.ά.
Έκδοση: (2023-02-01)

Upadacitinib for the treatment of psoriatic arthritis
ανά: Diogo Fonseca, κ.ά.
Έκδοση: (2023-02-01)

The Role of Vitamin D in Disease Activity in Axial Spondyloarthritis
ανά: Geraint Alun Brown, κ.ά.
Έκδοση: (2020-07-01)

Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
ανά: Peter Nash, κ.ά.
Έκδοση: (2018-11-01)

Editorial: Pathophysiology of bone and mineral metabolism
ανά: Elena Ambrogini, κ.ά.
Έκδοση: (2024-02-01)

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study
ανά: Karin Bengtsson, κ.ά.
Έκδοση: (2017-05-01)

Comparative characteristics of axial spondyloarthritis and psoriatic arthritis with axial involvement
ανά: Е. Е. Gubar, κ.ά.
Έκδοση: (2024-04-01)

Are TNF-α and IL-1β Independently Associated with Depression in Axial Spondyloarthritis Patients? A Case-Control Study
ανά: Md. Nazrul Islam, κ.ά.
Έκδοση: (2024-01-01)

Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
ανά: Iain B. McInnes, κ.ά.
Έκδοση: (2022-10-01)

Axial Spondyloarthritis: Clinical Characteristics, Epidemiology, and General Approaches to Management
ανά: Conall MacGearailt, κ.ά.
Έκδοση: (2021-07-01)

Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-PerSpA data
ανά: Raquel Ena María Granados, κ.ά.
Έκδοση: (2023-06-01)

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
ανά: Matthias Jarlborg, κ.ά.
Έκδοση: (2020-05-01)

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
ανά: Sara Alonso, κ.ά.
Έκδοση: (2021-05-01)

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
ανά: Xenofon Baraliakos, κ.ά.
Έκδοση: (2023-04-01)

Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022
ανά: Jiao Wang, κ.ά.
Έκδοση: (2025-02-01)

Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study
ανά: Annalisa Marino, κ.ά.
Έκδοση: (2024-02-01)

Monosodium urate crystal deposition associated with the progress of radiographic grade at the sacroiliac joint in axial SpA: a dual-energy CT study
ανά: Junqing Zhu, κ.ά.
Έκδοση: (2017-05-01)

Zero echo time MRI improved detection of erosions and sclerosis in the sacroiliac joint in comparison with LAVA-flex
ανά: Churong Lin, κ.ά.
Έκδοση: (2023-05-01)

Psoriatic arthritis with atypical manifestations
ανά: Ivna Tomaš, κ.ά.
Έκδοση: (2023-01-01)

Etanercept in axial spondyloarthritis – treatment efficacy
ανά: I. Z. Gaydukova, κ.ά.
Έκδοση: (2022-03-01)

Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data
ανά: Ian C. Scott, κ.ά.
Έκδοση: (2022-12-01)

A case of rheumatoid spondyloarthritis!
ανά: Sujatha N, κ.ά.
Έκδοση: (2019-01-01)

Effectiveness and safety of secukinumab in axial spondyloarthritis and psoriatic arthritis: A retrospective analysis of its real-world usage from India
ανά: Sham Santhanam, κ.ά.
Έκδοση: (2020-01-01)